(Q43932881)

English

Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa

scientific article published on 16 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

0 references

Plasmodium falciparum

0 references

0 references

malaria vaccine

1 reference

based on heuristic

inferred from title

12

object named as

Simon Cousens

1 reference

Europe PubMed Central

28 November 2017

Sodiomon B Sirima

1

object named as

Sodiomon B Sirima

1 reference

Europe PubMed Central

28 November 2017

8

object named as

Amidou Diarra

1 reference

Europe PubMed Central

28 November 2017

4

object named as

Alfred B Tiono

1 reference

Europe PubMed Central

28 November 2017

Alphonse Ouédraogo

3

object named as

Alphonse Ouédraogo

1 reference

Europe PubMed Central

28 November 2017

Amadou T. Konaté

5

object named as

Amadou T Konaté

1 reference

Europe PubMed Central

28 November 2017

Issiaka Soulama

10

object named as

Issiaka Soulama

1 reference

Europe PubMed Central

28 November 2017

2

object named as

Issa Nébié

1 reference

Europe PubMed Central

28 November 2017

6

object named as

Adama Gansané

1 reference

Europe PubMed Central

28 November 2017

Amidou Z Ouédraogo

9

object named as

Amidou Ouédraogo

1 reference

Europe PubMed Central

28 November 2017

author name string

Assetou I Dermé

7

1 reference

Europe PubMed Central

28 November 2017

Nadine Cuzzin-Ouattara

11

1 reference

Europe PubMed Central

28 November 2017

Odile Leroy

13

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

16 June 2006

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

25

1 reference

Europe PubMed Central

28 November 2017

14

1 reference

Europe PubMed Central

28 November 2017

2723-2732

1 reference

Europe PubMed Central

28 November 2017

Number of African children dying from malaria approaches a million a year

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

The burden of malaria mortality among African children in the year 2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich pro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.090

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.05.090

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43932881&oldid=2104481425"